| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Jei-Man Ryu CEO | KRX SM Exchange | KR7019170000 ISIN |
| KR Country | 809 Employees | 29 Dec 2021 Last Dividend | 27 Dec 2013 Last Split | - IPO Date |
Shinpoong Pharmaceutical Co., Ltd. is a South Korean pharmaceutical company with a comprehensive portfolio of products and a significant global presence. Founded in 1962, the company has grown to become a notable player in the pharmaceutical industry, both domestically and internationally. Shinpoong Pharmaceutical manufactures and sells a wide range of pharmaceutical products, involving active pharmaceutical ingredients and finished products. Its operations encompass not just the production of various drugs but also extend to business management and international exports. With its products reaching around 50 countries, Shinpoong Pharmaceutical is committed to improving health care worldwide. The company's headquarters is located in Seoul, South Korea, serving as a central hub for its extensive research, development, and manufacturing activities.
Shinpoong Pharmaceutical Co., Ltd. offers an extensive lineup of pharmaceutical products and services, characterized by innovation and quality. These include:
In addition to its comprehensible portfolio of pharmaceutical products, Shinpoong Pharmaceutical is engaged in business management activities and leverages its expertise to facilitate a thriving export business, distributing its innovations to a global audience.